Fox Rothschild LLP

On March 23, the federal Small Business Administration (SBA) stated that cannabis businesses will not be eligible for loans under its Economic Injury Disaster Loan (EIDL) Program, despite expanding the
Continue Reading SBA Announces that Cannabis Businesses Will Not be Eligible for Economic Injury Disaster Loans

In recent days, the Governors of both New Jersey and Pennsylvania have ordered the closure of certain businesses deemed non-essential as part of each state’s COVID-19 mitigation efforts. Further guidance
Continue Reading New Jersey and Pennsylvania Medical Marijuana Dispensaries Remain Open Despite Other Business Closures

Although consumer appetite for CBD-containing products continues to grow, and the market for such products correspondingly expands, 2020 may be another year in which the regulatory roadmap remains unsettled. On
Continue Reading Industry and Consumers Still Waiting on Regulations Governing Products Containing Hemp-Derived CBD

This blog typically focuses on legal issues and developments affecting stakeholders operating within the cannabis industry. However, the legal dichotomy surrounding cannabis (i.e. federal law defines”marijuana” as an illegal controlled
Continue Reading Fox Rothschild Publishes National Survey on “Marijuana in the Workplace”

Over at Fox Rothschild’s California Employment Law Blog, my colleague Jeff Polsky wrote about a new law requiring California cannabis companies with 20+ employees to enter into a “labor
Continue Reading CA Cannabis Companies With 20+ Employees Must Certify They Have “Labor Peace”

Back in May, I blogged about a recommendation from the Pennsylvania Medical Marijuana Advisory Board to add Anxiety and Tourette Syndrome as “serious medical conditions” covered under the Pennsylvania Medical
Continue Reading Pennsylvania Adds Anxiety & Tourette Syndrome as “Serious Medical Conditions” under the PA Medical Marijuana Act